News & Analysis as of

Artificial Intelligence › IP License › Startups

Fenwick & West LLP

What Startups and Big Pharma Need to Know About AI Drug Discovery

Fenwick & West LLP on

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property (IP) risks, licensing...more

Knobbe Martens

Funding Strategies in the Generative AI World – Why Patents Should Still Matter to Investors: A Conversation with Technology...

Knobbe Martens on

In this episode of the Knobbe IP+ podcast, Knobbe Martens partner Mauricio A. Uribe speaks with author, technology disruptor, strategist and CEO Linda Bernardi on the role of patent strategies in VC funding opportunities and...more

Foley & Lardner LLP

Remodeling your Artificial Intelligence IP Strategy: Top 3 reasons to invest in your IP

Foley & Lardner LLP on

Artificial intelligence has weaved its way into almost every industry, from detecting cancer to predicting employee performance to teaching robots and vehicles to use all kinds of sensor data to make human-like decisions in...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide